PROMAB Trademark

Trademark Overview

On Monday, November 18, 2013, a trademark application was filed for PROMAB with the United States Patent and Trademark Office. The USPTO has given the PROMAB trademark a serial number of 86121083. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 4, 2024. This trademark is owned by ProMab Biotechnologies, Inc.. The PROMAB trademark is filed in the Chemical Products category with the following description:

Reagents for research purposes, namely, stem cells, monoclonal antibodies, and recombinant proteins
promab

General Information

Serial Number86121083
Word MarkPROMAB
Filing DateMonday, November 18, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 4, 2024
Registration Number4579150
Registration DateTuesday, August 5, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2014

Trademark Statements

Goods and ServicesReagents for research purposes, namely, stem cells, monoclonal antibodies, and recombinant proteins

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, December 2, 2013
Primary Code001
First Use Anywhere DateWednesday, March 1, 2000
First Use In Commerce DateWednesday, March 1, 2000

Trademark Owner History

Party NameProMab Biotechnologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond, CA 94806
Party NameProMab Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond, CA 94806
Party NameProMab Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond, CA 94806

Trademark Events

Event DateEvent Description
Thursday, November 21, 2013NEW APPLICATION ENTERED
Monday, December 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 5, 2014ASSIGNED TO EXAMINER
Tuesday, March 11, 2014NON-FINAL ACTION WRITTEN
Tuesday, March 11, 2014NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 20, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 15, 2014ASSIGNED TO LIE
Tuesday, April 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 20, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 20, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 5, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 5, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 27, 2020TEAS SECTION 8 RECEIVED
Monday, October 26, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 27, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, October 27, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, August 5, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 14, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, April 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 4, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, July 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 1, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

promab monoclonal antibodies recombinant proteins cells stem research purposes namely reagents